These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 32897166)

  • 1. Two types of colistin heteroresistance in
    Hong YK; Kim H; Ko KS
    Emerg Microbes Infect; 2020 Dec; 9(1):2114-2123. PubMed ID: 32897166
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multiple heteroresistance to tigecycline and colistin in Acinetobacter baumannii isolates and its implications for combined antibiotic treatment.
    Jo J; Kwon KT; Ko KS
    J Biomed Sci; 2023 Jun; 30(1):37. PubMed ID: 37287044
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Resistance and heteroresistance to colistin among clinical isolates of Acinetobacter baumannii.
    Çağlan E; Nigiz Ş; Sancak B; Gür D
    Acta Microbiol Immunol Hung; 2020 Jun; 67(2):107-111. PubMed ID: 31813259
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tigecycline Heteroresistance and Resistance Mechanism in Clinical Isolates of Acinetobacter baumannii.
    Jo J; Ko KS
    Microbiol Spectr; 2021 Oct; 9(2):e0101021. PubMed ID: 34523993
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Deciphering colistin heteroresistance in Acinetobacter baumannii clinical isolates from Wenzhou, China.
    Chen L; Lin J; Lu H; Zhang X; Wang C; Liu H; Zhang X; Li J; Cao J; Zhou T
    J Antibiot (Tokyo); 2020 Jul; 73(7):463-470. PubMed ID: 32152526
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Colistin heteroresistance in carbapenem-resistant Acinetobacter baumannii clinical isolates from a Thai university hospital.
    Thet KT; Lunha K; Srisrattakarn A; Lulitanond A; Tavichakorntrakool R; Kuwatjanakul W; Charoensri N; Chanawong A
    World J Microbiol Biotechnol; 2020 Jul; 36(7):102. PubMed ID: 32613355
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discrepancies in susceptibility testing to colistin in Acinetobacter baumannii: The influence of slow growth and heteroresistance.
    Rodriguez CH; Traglia G; Bastias N; Pandolfo C; Bruni G; Nastro M; Barrios R; Bavastro EM; Rey MC; Marques IA; Heger F; Vay C; Fernandez JS; Ramirez MS; Famiglietti A
    Int J Antimicrob Agents; 2019 Nov; 54(5):587-591. PubMed ID: 31400469
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular Mechanisms of Colistin Resistance Among Pandrug-Resistant Isolates of Acinetobacter baumannii with High Case-Fatality Rate in Intensive Care Unit Patients.
    Haeili M; Kafshdouz M; Feizabadi MM
    Microb Drug Resist; 2018 Nov; 24(9):1271-1276. PubMed ID: 29590004
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Contribution of efflux to colistin heteroresistance in a multidrug resistant Acinetobacter baumannii clinical isolate.
    Machado D; Antunes J; Simões A; Perdigão J; Couto I; McCusker M; Martins M; Portugal I; Pacheco T; Batista J; Toscano C; Viveiros M
    J Med Microbiol; 2018 Jun; 67(6):740-749. PubMed ID: 29717972
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of colistin heteroresistance in Acinetobacter baumannii from blood and respiratory isolates.
    Srinivas P; Hunt LN; Pouch SM; Thomas K; Goff DA; Pancholi P; Balada-Llasat JM; Bauer KA
    Diagn Microbiol Infect Dis; 2018 Jun; 91(2):194-198. PubMed ID: 29482871
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative evaluation of the VITEK 2, disk diffusion, etest, broth microdilution, and agar dilution susceptibility testing methods for colistin in clinical isolates, including heteroresistant Enterobacter cloacae and Acinetobacter baumannii strains.
    Lo-Ten-Foe JR; de Smet AM; Diederen BM; Kluytmans JA; van Keulen PH
    Antimicrob Agents Chemother; 2007 Oct; 51(10):3726-30. PubMed ID: 17646414
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Methods to Evaluate Colistin Heteroresistance in Acinetobacter baumannii.
    Sherman EX; Wozniak JE; Weiss DS
    Methods Mol Biol; 2019; 1946():39-50. PubMed ID: 30798542
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heteroresistance to colistin in multidrug-resistant Acinetobacter baumannii.
    Li J; Rayner CR; Nation RL; Owen RJ; Spelman D; Tan KE; Liolios L
    Antimicrob Agents Chemother; 2006 Sep; 50(9):2946-50. PubMed ID: 16940086
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Colistin heteroresistance in acinetobacter and its association with previous colistin therapy.
    Hawley JS; Murray CK; Jorgensen JH
    Antimicrob Agents Chemother; 2008 Jan; 52(1):351-2. PubMed ID: 17954699
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterisation of successive Acinetobacter baumannii isolates from a deceased haemophagocytic lymphohistiocytosis patient.
    Choi HJ; Kil MC; Choi JY; Kim SJ; Park KS; Kim YJ; Ko KS
    Int J Antimicrob Agents; 2017 Jan; 49(1):102-106. PubMed ID: 27842758
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acquisition of Tn6018-3' CS regions increases colistin MICs against Acinetobacter baumannii isolates harboring new variants of AbaRs.
    Savari M; Ekrami A; Shoja S; Bahador A
    Folia Microbiol (Praha); 2017 Sep; 62(5):373-379. PubMed ID: 28238067
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence and Clinical Consequences of Colistin Heteroresistance and Evolution into Full Resistance in Carbapenem-Resistant Acinetobacter baumannii.
    Kon H; Hameir A; Nutman A; Temkin E; Keren Paz A; Lellouche J; Schwartz D; Weiss DS; Kaye KS; Daikos GL; Skiada A; Durante-Mangoni E; Dishon Benattar Y; Yahav D; Daitch V; Bernardo M; Iossa D; Friberg LE; Theuretzbacher U; Leibovici L; Dickstein Y; Pollak D; Mendelsohn S; Paul M; Carmeli Y
    Microbiol Spectr; 2023 Jun; 11(3):e0509322. PubMed ID: 37219426
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Colistin Heteroresistance and Involvement of the PmrAB Regulatory System in Acinetobacter baumannii.
    Charretier Y; Diene SM; Baud D; Chatellier S; Santiago-Allexant E; van Belkum A; Guigon G; Schrenzel J
    Antimicrob Agents Chemother; 2018 Sep; 62(9):. PubMed ID: 29914966
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diversity of amino acid substitutions in PmrCAB associated with colistin resistance in clinical isolates of Acinetobacter baumannii.
    Gerson S; Lucaßen K; Wille J; Nodari CS; Stefanik D; Nowak J; Wille T; Betts JW; Roca I; Vila J; Cisneros JM; Seifert H; Higgins PG
    Int J Antimicrob Agents; 2020 Mar; 55(3):105862. PubMed ID: 31837449
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Colistin hetero-resistance in multidrug-resistant Acinetobacter baumannii clinical isolates from the Western Pacific region in the SENTRY antimicrobial surveillance programme.
    Yau W; Owen RJ; Poudyal A; Bell JM; Turnidge JD; Yu HH; Nation RL; Li J
    J Infect; 2009 Feb; 58(2):138-44. PubMed ID: 19058855
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.